(Q44049871)

29 November 2017

title

In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets (English)

1 reference

29 November 2017

S Peppoloni

1

1 reference

29 November 2017

B J Mathieson

2

1 reference

29 November 2017

R B Herberman

3

1 reference

29 November 2017

R W Overton

4

1 reference

29 November 2017

E Gorelik

5

1 reference

29 November 2017

publication date

1 January 1987

1 reference

Cancer Immunology, Immunotherapy

29 November 2017

published in

1 reference

29 November 2017

volume

24

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

49-56

1 reference

Cytotoxic monoclonal antibody specific for the Lyt-1.2 antigen

29 November 2017

cites work

1 reference

12 December 2020

A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.

1 reference

12 December 2020

Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies

1 reference

12 December 2020

Differential effects of cyclophosphamide on the B and T cell compartments of adult mice

1 reference

12 December 2020

Thy and Ly markers on lymphocytes initiating tumor rejection.

1 reference

12 December 2020

The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro

1 reference

12 December 2020

Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.

1 reference

12 December 2020

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

1 reference

12 December 2020

Contribution of host immunity to cyclophosphamide therapy of a chemically-induced murine sarcoma

1 reference

12 December 2020

Mechanisms of immunosuppression: effects of cyclophosphamide on cellular immunity

1 reference

12 December 2020

Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

1 reference

12 December 2020

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

12 December 2020

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice

1 reference

12 December 2020

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

1 reference

12 December 2020

Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo

1 reference

12 December 2020

Cyclophosphamide: Use in Practice

1 reference

12 December 2020

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 reference

12 December 2020

Ly 9, an alloantigenic marker of lymphocyte differentiation

1 reference

12 December 2020

Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations

1 reference

12 December 2020

Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

1 reference

12 December 2020

The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour

1 reference

12 December 2020

Restoration of cyclophosphamide-induced suppression of thymus-derived cytotoxic cell generation by normal thymocytes

1 reference

12 December 2020

Depressed T-cell reactivity and suppressor activity of lymoid cells from cyclophosphamide-treated mice

1 reference

12 December 2020

Effectiveness of Murine Leukemia Chemotherapy According to the Immune State: Reconsideration of Correlations Between Chemotherapy, Tumour Cell Killing, and Survival Time

1 reference

12 December 2020

The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro

1 reference

12 December 2020

Effects of chemotherapeutic agents on the immune response. I

1 reference

12 December 2020

Mechanisms of immunosuppression: effects of cyclophosphamide on lymphocytes

1 reference

12 December 2020

Proportional increase in the theta carrying lymphocytes in peripheral lymphoid tissue following treatment with cyclophosphamide.

1 reference

12 December 2020

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

1 reference

12 December 2020

T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors

1 reference

12 December 2020

Inhibition of cytotoxic T-cell clonal expansion by cyclophosphamide and the recovery of cytotoxic T-lymphocyte precursors by supernatants from mixed-lymphocyte cultures

1 reference

12 December 2020

A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection

1 reference

12 December 2020

Recovery of the capacity for cytotoxic T cell generation in cyclophosphamide-treated mice by the addition of LYT-1/2- helper cells

1 reference

12 December 2020

The Effect of Cyclophospkamide on the Immune Response

1 reference

12 December 2020

Lyt 1+23- cells appear in the thymus before Lyt 123+ cells.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199832

1 reference

29 November 2017

1 reference